131 related articles for article (PubMed ID: 7107370)
1. In vivo testing of a 2-nitroimidazole radiosensitizer (Ro 03-8799) using repeated administration.
Williams MV; Denekamp J; Minchinton AI; Stratford MR
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):477-81. PubMed ID: 7107370
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of basic 2-nitroimidazole radiosensitizers.
Williams MV; Denekamp J; Minchinton AI; Stratford MR
Br J Cancer; 1982 Jul; 46(1):127-37. PubMed ID: 7104192
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
Reddy EK
Br J Cancer Suppl; 1978 Jun; 3():250-4. PubMed ID: 277241
[TBL] [Abstract][Full Text] [Related]
4. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
5. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies using multiple administration of RO 03-8799, a 2-nitroimidazole radiosensitizer.
Stratford MR; Minchinton AI; Hill SA; McNally NJ; Williams MV
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):469-71. PubMed ID: 7107368
[TBL] [Abstract][Full Text] [Related]
7. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
Tada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
[TBL] [Abstract][Full Text] [Related]
8. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
9. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
11. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
[TBL] [Abstract][Full Text] [Related]
12. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
DeGraff WG; Russo A; Gamson J; Mitchell JB
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Hei TK; Geard CR; Osmak RS; Hall EJ
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
[TBL] [Abstract][Full Text] [Related]
16. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Brown JM; Yu NY; Brown DM; Lee WW
Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):695-703. PubMed ID: 6457018
[No Abstract] [Full Text] [Related]
17. Cellular uptake of misonidazole and analogues with acidic or basic functions.
Dennis MF; Stratford MR; Wardman P; Watts ME
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of the RIF-1 murine flank tumor by desmethylmisonidazole (Ro 05 9963) during interstitial brachytherapy.
Bernstein M; Gutin PH; Deen DF; Weaver KA; Levin VA; Barcellos MH
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):487-90. PubMed ID: 7107372
[TBL] [Abstract][Full Text] [Related]
19. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
20. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
Rofstad EK; Brustad T
Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
